Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Pilot Longitudinal Data Collection To Inform Public Health-Fragile X Syndrome, DD11-007, Initial Review, 13414 [2011-5628]

Download as PDF 13414 Federal Register / Vol. 76, No. 48 / Friday, March 11, 2011 / Notices Among Children and Adults in India, FOA IP11–012; Influenza Vaccine Efficacy in Tropical and Developing Countries, FOA IP11–013; and Influenza and Other Respiratory Diseases in Southern Hemisphere, FOA IP11–014; initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: DEPARTMENT OF HEALTH AND HUMAN SERVICES Time and Date: 8 a.m.–5 p. m., May 12, 2011 (Closed). Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, Georgia 30337, Telephone: (770) 997–1100. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Studies at the Animal-Human Interface of Influenza and Other Zoonotic Diseases in Vietnam, FOA IP11–005; The Incidence and Etiology of InfluenzaAssociated Community-Acquired Pneumonia in Hospitalized Persons Study, FOA IP11– 011; Spectrum of Respiratory Pathogens in Acute Respiratory Tract Infection Among Children and Adults in India, FOA IP11–012; Influenza Vaccine Efficacy in Tropical and Developing Countries, FOA IP11–013; and Influenza and Other Respiratory Diseases in Southern Hemisphere, FOA IP11–014, initial review.’’ Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 498–2293. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Dated: March 7, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. srobinson on DSKHWCL6B1PROD with NOTICES [FR Doc. 2011–5626 Filed 3–10–11; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Continuation of the National Mesothelioma Virtual Bank for Translational Research, Program Announcement PAR 11–002, Initial Review Time and Date: 2 p.m.–4 p.m., April 5, 2011 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of ‘‘Continuation of the National Mesothelioma Virtual Bank for Translational Research, PAR 11–002.’’ Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E74, Atlanta, Georgia 30333, Telephone: (404) 498–2543. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: March 3, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–5630 Filed 3–10–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Pilot Longitudinal Data Collection To Inform Public Health—Fragile X Syndrome, DD11–007, Initial Review Notice of Cancellation: This notice was published in the Federal Register on December 17, 2010, Volume 75, Number 242, page 78997. VerDate Mar<15>2010 17:08 Mar 10, 2011 Jkt 223001 PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 This SEP previously scheduled to convene on April 15, 2011, is cancelled in its entirety. Contact Person for More Information: Donald Blackman, Ph.D., Scientific Review Officer, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office of the Director, Extramural Research Program Office, 4770 Buford Highway, NE., Mailstop K– 92, Atlanta, Georgia 30341, Telephone: (770) 488–3023, E-mail: DBY7@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: March 4, 2011. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–5628 Filed 3–10–11; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Evaluation of the Impact of Work or School Exclusion Criteria on the Spread of Influenza and Influenza-Like-Illness (U01), Funding Opportunity Number (FOA) CK11–007, Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 8 a.m.–5 p.m., May 2, 2011 (Closed). Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan Road, Atlanta, Georgia 30337, Telephone: (770) 997–1100. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Evaluation of the Impact of Work or School Exclusion Criteria on the Spread of Influenza and Influenza-like-Illness (U01), FOA CK11–007.’’ Contact Person for More Information: Dr. Amy Yang, Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, E:\FR\FM\11MRN1.SGM 11MRN1

Agencies

[Federal Register Volume 76, Number 48 (Friday, March 11, 2011)]
[Notices]
[Page 13414]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-5628]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Pilot Longitudinal Data Collection To Inform 
Public Health--Fragile X Syndrome, DD11-007, Initial Review

    Notice of Cancellation: This notice was published in the Federal 
Register on December 17, 2010, Volume 75, Number 242, page 78997.
    This SEP previously scheduled to convene on April 15, 2011, is 
cancelled in its entirety.
    Contact Person for More Information: Donald Blackman, Ph.D., 
Scientific Review Officer, CDC, National Center for Chronic Disease 
Prevention and Health Promotion, Office of the Director, Extramural 
Research Program Office, 4770 Buford Highway, NE., Mailstop K-92, 
Atlanta, Georgia 30341, Telephone: (770) 488-3023, E-mail: 
DBY7@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: March 4, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2011-5628 Filed 3-10-11; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.